Delivery Order SPE2DB20D9331-SPE2DB21FL1Y2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,022.86, is for the delivery of Purixan 20 mg/ml oral suspension, a pharmaceutical product. The delivery order contract is part of a larger indefinite delivery vehicle (IDV) contract held by DMS Pharmaceutical Group with the DLA, valued at up to $4,999,999 through 2025. This IDV enables...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $2,045.74, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,022.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Purixan 20 mg/ml oral suspension in 100 ml containers, and has an ultimate completion date of December 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Purixan 20 mg/ml oral suspension in 100 ml quantities. This $6,371.04 firm fixed-price delivery order was awarded on August 7, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis leveraging...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,091.44 contract is for the delivery of Purixan 20 mg/ml oral suspension in 100ml bottles, and has an ultimate completion date of October 1, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Purixan 20 mg/ml oral suspension in 100ml quantities. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries firm fixed-price terms and was not issued under any set-aside designation. The order falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $4,247.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 9, 2025. The delivery order is for Purixan 20 mg/ml oral suspension in 100ml units, with completion targeted for September 30, 2025. This award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Purixan 20 mg/ml oral suspension in 100ml quantities. This delivery order, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, represents a firm fixed-price contract with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's...
- This is a $1,061.84 firm-fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of PURIXAN 20 MG/ML ORAL SUSP 100ML to the Defense Logistics Agency (DLA), a defense agency. The delivery order has a period of performance ending on July 3, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued up to $3,852.56, is for the delivery of PURIXAN 20 MG/ML ORAL SUSP 100ML, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which allows the DLA to...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB21FL1Y2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,331.04 order is for the supply of Purixan, a 20 mg/mL oral suspension medication, with a completion date of October 19, 2021. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999 and running through December 31, 2025. The IDC allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 9/27/21 |